EUVIMEDEUVIMED entdecken
Crossref

Characterizing metabolic dysregulation in early-stage chronic kidney disease for diagnostic insights

Upasna Gupta, Amrita Sahu, Dharmendra Singh Bhadauria, Bikash Baishya, Neeraj Sinha

Molecular Omics · 2025

DOI: 10.1039/d5mo00018a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Omics, 2025. Verfasst von Upasna Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Biomedical Research, Sanjay Gandhi Post Institute of Medical Sciences Campus, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India. neeraj…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Metabolomics, Metabolome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Life Sciences Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progressive illness known as chronic kidney disease (CKD) can often be challenging to diagnose in its early stages with conventional diagnostic approaches such as serum creatinine and albumin assessment. Early-stage CKD (stages G1–G3) is defined by a GFR of ≥30 mL min−1/1.73 m2, which indicates normal to moderately reduced kidney function with or without symptoms of impaired kidney function. Identifying possible biomarkers for early detection and personalised treatment, as well as physiological changes linked to early CKD—an area that has not been fully investigated before—is the goal of the study to address this gap. We performed a metabolomic analysis using 1H NMR on 115 human serum samples (24 healthy controls and 91 patients with early-stage CKD). MetaboAnalyst 6.0 was used for data pre-processing and statistical analyses (PCA, PLS-DA, OPLS-DA, ANOVA, and Wilcoxon Mann–Whitney test). Strong differentiation between CKD stages was achieved by random forest modelling. The KEGG database was used to perform pathway enrichment, and ROC analysis was used to evaluate the diagnostic value of important metabolites. Across CKD stages, significant changes were observed in ten different metabolites: myo-Inositol, glycerol, pyruvate, carnitine, phenylalanine, tyrosine, histidine, TMAO, 2-hydroxyisobutyrate, and 3-hydroxyisobutyrate (p < 0.05, VIP > 1). AUC values > 0.7 from ROC curves demonstrated its potential for diagnosis. Pathway analysis revealed significant dysregulation in the metabolism of inositol phosphate, tyrosine, histidine, and pyruvate, and biosynthesis of phenylalanine, tryptophan and tyrosine. This comprehensive metabolomics investigation identified potential early-stage CKD biomarkers in addition to significant metabolic abnormalities. These findings could help provide individualized care for early CKD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicMetabolomicsMetabolomeHumansMaleFemaleMiddle AgedBiomarkersAdultAgedCase-Control StudiesGlomerular Filtration RateROC Curve

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Centre of Biomedical Research, Sanjay Gandhi Post Institute of Medical Sciences Campus, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India. neerajcbmr@gmail.com.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Department of Nephrology and Renal Transplantation, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, 226014, India. docdharm10@gmail.com.

Förderung

  • Life Sciences Research Board

Zitieren

APA

Gupta, U., Sahu, A., Bhadauria, D. S., Baishya, B., & Sinha, N. (2025). Characterizing metabolic dysregulation in early-stage chronic kidney disease for diagnostic insights. Molecular Omics. https://doi.org/10.1039/d5mo00018a

Vancouver

Gupta U, Sahu A, Bhadauria DS, Baishya B, Sinha N. Characterizing metabolic dysregulation in early-stage chronic kidney disease for diagnostic insights. Molecular Omics. 2025. doi:10.1039/d5mo00018a

BibTeX
@article{Gupta2025,
  author = {Gupta, Upasna and Sahu, Amrita and Bhadauria, Dharmendra Singh and Baishya, Bikash and Sinha, Neeraj},
  title = {Characterizing metabolic dysregulation in early-stage chronic kidney disease for diagnostic insights},
  journal = {Molecular Omics},
  year = {2025},
  doi = {10.1039/d5mo00018a}
}
Kostenlos starten →